Cargando…

An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding

Sitosterolemia (OMIM #210250) is a rare lipid disorder caused by variants in genes encoding adenosine triphosphate (ATP)-binding cassette subfamily G Member 5 (ABCG5) or 8 (ABCG8), which play roles in the intestinal and biliary excretion of cholesterol and plant sterols, such as sitosterol and campe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Aya, Aoyama, Kohei, Yamaguchi, Naoya, Suzuki, Atsushi, Mizuno, Haruo, Tada, Hayato, Saitoh, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068626/
https://www.ncbi.nlm.nih.gov/pubmed/37020702
http://dx.doi.org/10.1297/cpe.2022-0075
_version_ 1785018700133302272
author Yoshida, Aya
Aoyama, Kohei
Yamaguchi, Naoya
Suzuki, Atsushi
Mizuno, Haruo
Tada, Hayato
Saitoh, Shinji
author_facet Yoshida, Aya
Aoyama, Kohei
Yamaguchi, Naoya
Suzuki, Atsushi
Mizuno, Haruo
Tada, Hayato
Saitoh, Shinji
author_sort Yoshida, Aya
collection PubMed
description Sitosterolemia (OMIM #210250) is a rare lipid disorder caused by variants in genes encoding adenosine triphosphate (ATP)-binding cassette subfamily G Member 5 (ABCG5) or 8 (ABCG8), which play roles in the intestinal and biliary excretion of cholesterol and plant sterols, such as sitosterol and campesterol. Although considered an autosomal recessive disorder, recent reports have shown that a heterozygous ABCG5 variant can also cause mild symptoms. Here, we report the case of an infant with a heterozygous variant of ABCG5. A 6-mo-old breast-fed Japanese male infant was found to have elevated serum total cholesterol and low-density lipoprotein-cholesterol (LDL-C) levels of 528 mg/dL and 449 mg/dL, respectively, upon examination for growth disturbances. As weaning progressed, the cholesterol levels normalized. Genetic analysis revealed that the patient and his mother had the heterozygous variant c.1166G>A (p.Arg389His) in ABCG5. Compared to his father, who did not have the ABCG5 variant, the patient and his mother had mild elevations of serum sitosterol and campesterol. Serum sitosterol and campesterol levels were 9.6 and 12 μg/mL for the patient, 4.9 and 9.3 μg/mL for his mother, and 2.1 and 3.4 μg/mL for his father, respectively. Therefore, heterozygous variants of ABCG5 may lead to transient hypercholesterolemia during breastfeeding.
format Online
Article
Text
id pubmed-10068626
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Japanese Society for Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-100686262023-04-04 An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding Yoshida, Aya Aoyama, Kohei Yamaguchi, Naoya Suzuki, Atsushi Mizuno, Haruo Tada, Hayato Saitoh, Shinji Clin Pediatr Endocrinol Case Report Sitosterolemia (OMIM #210250) is a rare lipid disorder caused by variants in genes encoding adenosine triphosphate (ATP)-binding cassette subfamily G Member 5 (ABCG5) or 8 (ABCG8), which play roles in the intestinal and biliary excretion of cholesterol and plant sterols, such as sitosterol and campesterol. Although considered an autosomal recessive disorder, recent reports have shown that a heterozygous ABCG5 variant can also cause mild symptoms. Here, we report the case of an infant with a heterozygous variant of ABCG5. A 6-mo-old breast-fed Japanese male infant was found to have elevated serum total cholesterol and low-density lipoprotein-cholesterol (LDL-C) levels of 528 mg/dL and 449 mg/dL, respectively, upon examination for growth disturbances. As weaning progressed, the cholesterol levels normalized. Genetic analysis revealed that the patient and his mother had the heterozygous variant c.1166G>A (p.Arg389His) in ABCG5. Compared to his father, who did not have the ABCG5 variant, the patient and his mother had mild elevations of serum sitosterol and campesterol. Serum sitosterol and campesterol levels were 9.6 and 12 μg/mL for the patient, 4.9 and 9.3 μg/mL for his mother, and 2.1 and 3.4 μg/mL for his father, respectively. Therefore, heterozygous variants of ABCG5 may lead to transient hypercholesterolemia during breastfeeding. The Japanese Society for Pediatric Endocrinology 2023-02-28 2023 /pmc/articles/PMC10068626/ /pubmed/37020702 http://dx.doi.org/10.1297/cpe.2022-0075 Text en 2023©The Japanese Society for Pediatric Endocrinology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Case Report
Yoshida, Aya
Aoyama, Kohei
Yamaguchi, Naoya
Suzuki, Atsushi
Mizuno, Haruo
Tada, Hayato
Saitoh, Shinji
An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding
title An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding
title_full An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding
title_fullStr An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding
title_full_unstemmed An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding
title_short An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding
title_sort infant with a heterozygous variant of abcg5 presented with hypercholesterolemia only during breastfeeding
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068626/
https://www.ncbi.nlm.nih.gov/pubmed/37020702
http://dx.doi.org/10.1297/cpe.2022-0075
work_keys_str_mv AT yoshidaaya aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT aoyamakohei aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT yamaguchinaoya aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT suzukiatsushi aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT mizunoharuo aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT tadahayato aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT saitohshinji aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT yoshidaaya infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT aoyamakohei infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT yamaguchinaoya infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT suzukiatsushi infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT mizunoharuo infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT tadahayato infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding
AT saitohshinji infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding